Wiley Periodicals, Inc

SHERPA: Unknown

People

  1. Modak
    Modak
  2. Kushner
    Kushner
  3. Cheung
    Cheung
  4. Kramer
    Kramer
  5. Basu
    Basu
  6. Pandit-Taskar
    Pandit-Taskar
  7. La Quaglia
    La Quaglia
  8. Wolden
    Wolden
  9. Carrasquillo
    Carrasquillo
  10. Mauguen
    Mauguen

Groups

  1. Neuroblastoma Service (68)
  2. Pediatrics, Department of (68)
  3. GSK Faculty (52)
  4. Tow Center for Developmental Oncology (TCDO) (52)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (49)
  6. Center for Hematologic Malignancies (31)
  7. Center for Molecular Imaging and Biotechnology (CMIB) (30)
  8. Neuro-Oncology Service (30)
  9. Pediatric Leukemia (26)
  10. Center for Molecular Imaging and Biotechnology (22)
Search Within
  1. "Shakeel Modak"
Formats
  1. Meeting Abstract (41)
  2. Journal Article (27)
Groups
  1. Neuroblastoma Service (68)
  2. Pediatrics, Department of (68)
  3. GSK Faculty (52)
  4. Tow Center for Developmental Oncology (TCDO) (52)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (49)
  6. Center for Hematologic Malignancies (31)

More Groups

People
  1. Shakeel Modak (68)
  2. Brian Kushner (51)
  3. Nai-Kong Cheung (49)
  4. Kim Kramer (28)
  5. Ellen Basu (27)
  6. Stephen Roberts (24)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (3)
  4. 2021 (6)
  5. 2020 (7)
  6. 2019 (9)

More Years

Publications
  1. Pediatric Blood and Cancer (68)

Results (68)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Acute myeloid leukemia therapy elicits durable complete response in chemoradio-resistant metastatic paraganglioma
    Journal Article

    Sait, S.; Kobos, R.; LaQuaglia, M. P.; Pandit-Taskar, N.; Modak, S.
    Pediatric Blood and Cancer (2017)

    Fulltext@MSK | Save
  • Phase II study of arsenic trioxide in neuroblastoma and other paediatric solid tumors
    Meeting Abstract

    Kudva, A.; Kushner, B.; Modak, S.
    Pediatric Blood and Cancer (2016)

    Fulltext@MSK | Save
  • Is extended sedation necessary for young children receiving high-dose 131I-MIBG therapy?
    Journal Article

    Modak, S.; Santopolo, S.; Chu, B.; Basu, E.
    Pediatric Blood and Cancer (2016)

    Fulltext@MSK | Save
  • Germline mutations in cancer predisposition genes in a subset of pediatric oncology patients undergoing targeted solid tumor sequencing using matched normal DNA
    Meeting Abstract

    Walsh, M.; Shukla, N.; Joseph, V.; Kentsis, A.; Curran, K.; Kobos, R.; Arnold, A.; Harlan, M.; Kennedy, J.; Schrader, K.; more...
    Pediatric Blood and Cancer (2016)

    Fulltext@MSK | Save
  • Feasibility of administering high-dose (131)I-MIBG therapy to children with high-risk neuroblastoma without lead-lined rooms
    Journal Article

    Chu, B. P.; Horan, C.; Basu, E.; Dauer, L.; Williamson, M.; Carrasquillo, J. A.; Pandit-Taskar, N.; Modak, S.
    Pediatric Blood and Cancer (2016)

    Fulltext@MSK | Save
  • Curettage for focal high-risk skeletal neuroblastoma resistant to chemotherapy and radiotherapy
    Meeting Abstract

    Salman, Z.; Kushner, B. H.; Cheung, N. K. V.; Basu, E.; Roberts, S.; Wolden, S.; Mora, J.; Modak, S.
    Pediatric Blood and Cancer (2015)

    Fulltext@MSK | Save
  • Relapse in patients with high-risk neuroblastoma after treatment with 3F8+GM-CSF+CIS-retinoic acid in first complete/very good partial remission: Patterns, management and long-term outcome
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Kramer, K.; Basu, E.; Roberts, S. S.; Chamberlain, E.; Wolden, S.; Laquaglia, M.; Cheung, N. K. V.
    Pediatric Blood and Cancer (2015)

    Fulltext@MSK | Save
  • Central line associated blood stream infections (CLABSIS) in pediatric oncology at Memorial Sloan-Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Ambati, S.; Lentini-Rivera, A.; Son, C.; Chlosta, S.; Kahn, A.; Eagan, J.; La Quaglia, M.; Modak, S.
    Pediatric Blood and Cancer (2013)

    Fulltext@MSK | Save
  • Phase II study of the combination of bevacizumab plus irinotecan and temozolomide for relapsed or refractory neuroblastoma: Preliminary results
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Kramer, K.; Basu, E.; Roberts, S. S.; Cheung, N. K. V.
    Pediatric Blood and Cancer (2012)

    Fulltext@MSK | Save
  • Haploidentical natural killer cells plus monoclonal antibody 3F8 for resistant high-risk neuroblastoma: Preliminary results of an ongoing phase I study
    Meeting Abstract

    Modak, S.; Cheung, N. K. V.; Kushner, B. H.; Kramer, K.; Basu, E.; Roberts, S. S.; Gallagher, M.; Hsu, K.
    Pediatric Blood and Cancer (2012)

    Fulltext@MSK | Save